Fulvestrant falsely elevates oestradiol levels in immunoassays in postmenopausal women with breast cancer

Eur J Cancer. 2020 Feb:126:104-105. doi: 10.1016/j.ejca.2019.10.015. Epub 2020 Jan 9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms / blood
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Chromatography, Liquid / methods
  • Estradiol / blood*
  • Female
  • Fulvestrant / therapeutic use*
  • Humans
  • Immunoassay / methods*
  • Middle Aged
  • Postmenopause / blood*
  • Reproducibility of Results
  • Tandem Mass Spectrometry / methods

Substances

  • Antineoplastic Agents, Hormonal
  • Fulvestrant
  • Estradiol